Growth driven by AI integration and a simpler business model after its ice cream spin-off. : Cited as a "Wide Moat" stock by Morningstar .
Maintains a "Wide Moat" rating due to its dominance in the drug manufacturing sector. Identified as a top European sector pick for Q1 2026. overseas stocks to buy
Identified as a top pick for 2026 by analysts at Jefferies and Susquehanna . Price targets range from . Growth driven by AI integration and a simpler